CORTESE, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 4.936
AS - Asia 3.046
EU - Europa 2.499
SA - Sud America 534
Continente sconosciuto - Info sul continente non disponibili 177
AF - Africa 139
OC - Oceania 9
Totale 11.340
Nazione #
US - Stati Uniti d'America 4.782
SG - Singapore 973
CN - Cina 816
IE - Irlanda 581
HK - Hong Kong 414
BR - Brasile 410
IT - Italia 401
DE - Germania 367
RU - Federazione Russa 354
VN - Vietnam 323
FI - Finlandia 241
FR - Francia 177
BD - Bangladesh 124
IN - India 119
GB - Regno Unito 100
CA - Canada 80
ZA - Sudafrica 71
JP - Giappone 51
MX - Messico 46
AR - Argentina 44
ES - Italia 41
BE - Belgio 38
IQ - Iraq 37
AT - Austria 28
SE - Svezia 28
NL - Olanda 27
PL - Polonia 23
TR - Turchia 23
CO - Colombia 20
PK - Pakistan 20
CZ - Repubblica Ceca 18
UA - Ucraina 17
ID - Indonesia 16
LT - Lituania 15
MA - Marocco 15
UZ - Uzbekistan 14
EC - Ecuador 13
MY - Malesia 13
VE - Venezuela 13
PH - Filippine 12
KE - Kenya 11
CR - Costa Rica 10
PY - Paraguay 10
SA - Arabia Saudita 9
AU - Australia 8
CL - Cile 8
ET - Etiopia 8
KR - Corea 8
AE - Emirati Arabi Uniti 7
EG - Egitto 7
JO - Giordania 7
TN - Tunisia 7
BO - Bolivia 6
IR - Iran 6
KZ - Kazakistan 6
TH - Thailandia 6
PE - Perù 5
PT - Portogallo 5
SI - Slovenia 5
AO - Angola 4
DZ - Algeria 4
HR - Croazia 4
JM - Giamaica 4
MU - Mauritius 4
NP - Nepal 4
PR - Porto Rico 4
TT - Trinidad e Tobago 4
AM - Armenia 3
AZ - Azerbaigian 3
BG - Bulgaria 3
BH - Bahrain 3
IL - Israele 3
KG - Kirghizistan 3
KH - Cambogia 3
LB - Libano 3
MD - Moldavia 3
TW - Taiwan 3
UY - Uruguay 3
AL - Albania 2
BY - Bielorussia 2
CH - Svizzera 2
EE - Estonia 2
GR - Grecia 2
GT - Guatemala 2
GY - Guiana 2
IS - Islanda 2
LV - Lettonia 2
MN - Mongolia 2
NO - Norvegia 2
OM - Oman 2
QA - Qatar 2
RO - Romania 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CY - Cipro 1
GE - Georgia 1
Totale 11.149
Città #
Chandler 597
Singapore 584
Dublin 573
Ashburn 530
San Jose 526
Hong Kong 400
Dallas 334
Beijing 224
Munich 219
Boardman 182
Council Bluffs 160
Helsinki 160
Los Angeles 157
Lauterbourg 118
Ho Chi Minh City 112
New York 107
Princeton 100
Lawrence 97
Wilmington 95
Hanoi 80
Redondo Beach 74
Medford 71
Shanghai 67
Moscow 66
Nanjing 62
Rome 61
Santa Clara 61
São Paulo 61
Milan 57
Johannesburg 56
Ann Arbor 50
Pavia 49
Tokyo 48
Turku 48
Jacksonville 43
Buffalo 42
Chicago 38
Brussels 34
Orem 33
Atlanta 30
Seattle 30
Montreal 29
Nuremberg 29
Nanchang 27
Washington 27
Brooklyn 26
Frankfurt am Main 25
Chennai 23
Pune 23
Columbus 22
The Dalles 22
Toronto 22
Fairfield 21
Jiaxing 21
Shenyang 21
London 20
Stockholm 20
Warsaw 20
Hebei 18
Changsha 17
Woodbridge 17
Da Nang 16
Manchester 16
Mexico City 16
Norwalk 16
Baghdad 15
Denver 15
Florence 15
San Francisco 15
Palermo 14
Tashkent 14
Amsterdam 13
Charlotte 13
Phoenix 13
Tianjin 13
Cambridge 12
Guangzhou 12
Hangzhou 12
Houston 12
Mumbai 12
Falls Church 11
Rio de Janeiro 11
Vienna 11
Boston 10
Dhaka 10
Nairobi 10
New Delhi 10
Piscataway 10
Poplar 10
Brno 9
Düsseldorf 9
Haiphong 9
Turin 9
Biên Hòa 8
Espoo 8
Hyderabad 8
Medellín 8
Naples 8
Querétaro 8
San José 8
Totale 7.335
Nome #
Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP Database 256
Bi-allelic genetic variants in the translational GTPases GTPBP1 and GTPBP2 cause a distinct identical neurodevelopmental syndrome 191
Contraction or sequence variant of an intergenic repeat-Alu element leads to inherited thyroid disease 189
Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment 162
AUTOIMMUNITY, ENVIRONMENT AND GENETICS IN INFLAMMATORY DISORDERS OF CENTRAL AND PERIPHERAL NERVOUS SYSTEM 154
Air pollution is associated to the multiple sclerosis inflammatory activity as measured by brain MRI 146
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study 146
RFC1 expansions are a common cause of idiopathic sensory neuropathy 139
Relevance of diagnostic investigations in chronic inflammatory demyelinating poliradiculoneuropathy: Data from the Italian CIDP database 135
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders 134
Cerebellar ataxia, neuropathy, vestibular areflexia syndrome due to RFC1 repeat expansion 134
Predictors of outcome in a large retrospective cohort of patients with transverse myelitis 132
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype 132
Diagnostics of dysimmune peripheral neuropathies 128
Atypical CIDP: Diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database 127
Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes 125
Air pollution as a contributor to the inflammatory activity of multiple sclerosis 125
Ambient air pollution boosts MS activity through upregulation of adhesion molecules and chemokine receptors on circulating lymphocytes 120
Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia 120
Impact of multiple sclerosis risk loci in postinfectious neurological syndromes 119
Neurofascin-155 as a putative antigen in combined central and peripheral demyelination 117
Diagnostics of anti-MAG antibody polyneuropathy 116
Diagnostic challenges in hereditary transthyretin amyloidosis with polyneuropathy: Avoiding misdiagnosis of a treatable hereditary neuropathy 114
Repurposing diflunisal for familial amyloid polyneuropathy: A randomized clinical trial 113
Altered TDP-43-dependent splicing in HSPB8-related distal hereditary motor neuropathy and myofibrillar myopathy 110
Multiple memory-guided saccades: movement memory improves the accuracy of memory-guided saccades 109
Impact of environmental factors and physical activity on disability and quality of life in CIDP 109
Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy 106
Diagnosis and therapy of acute disseminated encephalomyelitis and its variants 106
Absence of pathogenic mutations in CD59 in chronic inflammatory demyelinating polyradiculoneuropathy 104
Guillain-Barré syndrome associated with the D222E variant of the 2009 pandemic influenza A (H1N1) virus: Case report and review of the literature 104
Monitoring late complications of zinc treatment in Wilson's disease. Reply to the letter: Copper deficiency in Wilson's disease: An avoidable complication of treatment: Monitoring Late Complications of Zinc Treatment in Wilson's Disease 103
Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15 102
Variable echo time imaging for detecting the short T2* components of the sciatic nerve: a validation study 102
Author Correction: Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia (Nature Genetics, (2019), 51, 4, (649-658), 10.1038/s41588-019-0372-4) 102
A Māori specific RFC1 pathogenic repeat configuration in CANVAS, likely due to a founder allele 102
Author Correction: Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes (Nature Genetics, (2020), 52, 5, (473-481), 10.1038/s41588-020-0615-4) 101
MR microneurography and quantitative T2 and DP measurements of the distal tibial nerve in CIDP 100
Theta-Burst Stimulation of the Cerebellum Interferes with Internal Representations of Sensory-Motor Information Related to Eye Movements in Humans 99
Efficacy of rituximab as third-line therapy in combined central and peripheral demyelination 99
Erratum to: Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area (Journal of Neurology, DOI: 10.1007/s00415-016-8064-9) 98
Late onset oculopharyngeal muscular dystrophy with prominent neurogenic features and short GCG trinucleotide expansion 97
A CADM3 variant causes Charcot-Marie-Tooth disease with marked upper limb involvement 97
Muscle quantitative MRI as a novel biomarker in hereditary transthyretin amyloidosis with polyneuropathy: a cross-sectional study 97
Increased frequency of repeat expansion mutations across different populations 96
Mutation in RNF170 causes sensory ataxic neuropathy with vestibular areflexia: a CANVAS mimic 96
Corrigendum to “MR microneurography and quantitative T2 and DP measurements of the distal tibial nerve in CIDP” [Journal of the Neurological Sciences Volume 400, 15 May 2019, Pages 15–20](S0022510X19301145)(10.1016/j.jns.2019.03.001) 96
An ancestral 10-bp repeat expansion in VWA1 causes recessive hereditary motor neuropathy 96
Theta burst stimulation of the cerebellum impairs motor learning in humans. 95
Expression pattern of matrix metalloproteinases-2 and -9 and their tissue inhibitors in patients with chronic inflammatory demyelinating polyneuropathy 95
Truncating Variants in RFC1 in Cerebellar Ataxia, Neuropathy, and Vestibular Areflexia Syndrome 94
Progressive post infectious neurological syndromes with a poor outcome: Long term follow-up and neurofilament light chain quantification 94
Copper deficiency in Wilson's disease: Peripheral neuropathy and myelodysplastic syndrome complicating zinc treatment 94
Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy 93
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area 91
Spinocerebellar ataxia 27B: a frequent and slowly progressive autosomal-dominant cerebellar ataxia—experience from an Italian cohort 90
Assessing mNIS+7Ionis and international neurologists' proficiency in a familial amyloidotic polyneuropathy trial 90
Laryngeal and phrenic nerve involvement in a patient with hereditary neuropathy with liability to pressure palsies (HNPP) 89
A novel RFC1 repeat motif (ACAGG) in two Asia-Pacific CANVAS families 88
Botulinum toxin is effective in the management of neurogenic dysphagia. clinical-electrophysiological findings and tips on safety in different neurological disorders 87
Author response 87
Tissue-specific TCF4 triplet repeat instability revealed by optical genome mapping 86
Correction: Absence of pathogenic mutations in CD59 in chronic inflammatory demyelinating polyradiculoneuropathy (PLoS ONE (2019) 14: 2 (e0212647) DOI: 10.1371/journal.pone.0212647) 86
Neurological disorders caused by novel non-coding repeat expansions: clinical features and differential diagnosis 85
A CCG expansion in ABCD3 causes oculopharyngodistal myopathy in individuals of European ancestry 84
Cerebellar ataxia, neuropathy and vestibular areflexia syndrome (CANVAS): genetic and clinical aspects 83
Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial. 82
Remarkable Rituximab Response on Tremor Related to Acute-Onset Chronic Inflammatory Demyelinating Polyradiculoneuropathy in an Antineurofascin155 Immunoglobulin G4–Seropositive Patient 82
Natural History, Phenotypic Spectrum, and Discriminative Features of Multisystemic RFC1 Disease 82
Serum Neurofilament Light Chain in Replication Factor Complex Subunit 1 CANVAS and Disease Spectrum 81
CLINICAL FEATURES AND SEROLOGICAL PROFILE OF COMBINED CENTRAL AND PERIPHERAL DEMYELINATION 81
Erratum: Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1 81
Botulinum Toxin Is Effective in the Management of Neurogenic Dysphagia. Clinical-Electrophysiological Findings and Tips on Safety in Different Neurological Disorder 80
Novel CLN3 mutation causing autophagic vacuolar myopathy 80
Biallelic mutations in neurofascin cause neurodevelopmental impairment and peripheral demyelination 79
Quantitative MRI Assessment Using Variable Echo Time Imaging of Peripheral Nerve Injury in ATTRv Amyloidosis Patients 78
Normal and pathogenic variation of RFC1 repeat expansions: implications for clinical diagnosis 76
Genetic and phenotypic characterisation of inherited myopathies in a tertiary neuromuscular centre 75
Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1 75
Role of the repeat expansion size in predicting age of onset and severity in RFC1 disease 74
A study concept of expeditious clinical enrollment for genetic modifier studies in Charcot-Marie-Tooth neuropathy 1A 73
Widespread RNA metabolism impairment in sporadic inclusion body myositis TDP43-proteinopathy 71
Correlation of clinical and molecular features in spinal bulbar muscular atrophy 70
RFC1 expansions can mimic hereditary sensory neuropathy with cough and Sjögren syndrome 70
RFC1 repeat expansion in Japanese patients with late-onset cerebellar ataxia 70
AAGGG repeat expansions trigger RFC1 -independent synaptic dysregulation in human CANVAS neurons 69
Autosomal dominant optic atrophy and cataract "plus" phenotype including axonal neuropathy 68
Targeted next-generation sequencing panels in the diagnosis of Charcot-Marie-Tooth disease 68
Severe cognitive impairment in a patient with CMT2A 67
Longitudinal observational study of sporadic inclusion body myositis: Implications for clinical trials 67
CANVAS: case report on a novel repeat expansion disorder with late-onset ataxia 66
Heterozygous APTX mutation associated with atypical multiple system atrophy-like phenotype: A case report 65
Varicella zoster virus-associated polyradiculoneuritis 65
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 65
Whole genome sequencing increases the diagnostic rate in Charcot-Marie-Tooth disease 64
Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian database 64
Optical Genome Mapping Enables Detection and Accurate Sizing of RFC1 Repeat Expansions 63
Truncating Mutations in UBAP1 Cause Hereditary Spastic Paraplegia 62
Towards a standardised analysis of CSF in inflammatory neuropathies 62
Optical Genome Mapping for the Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy: Advancement and Challenges 61
Totale 9.852
Categoria #
all - tutte 53.487
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.487


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022485 0 3 7 14 14 35 9 37 40 4 68 254
2022/20231.553 150 132 24 163 105 166 8 75 658 14 36 22
2023/2024847 87 98 32 54 56 195 25 68 5 37 53 137
2024/20252.386 137 140 29 94 84 161 159 148 543 148 256 487
2025/20265.030 376 281 492 526 685 194 1.018 193 519 306 311 129
2026/2027469 276 193 0 0 0 0 0 0 0 0 0 0
Totale 11.340